Filing Details
- Accession Number:
- 0001209191-16-156270
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-12-21 12:11:48
- Reporting Period:
- 2016-12-19
- Filing Date:
- 2016-12-21
- Accepted Time:
- 2016-12-21 12:11:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1382911 | Orexigen Therapeutics Inc. | OREX | Pharmaceutical Preparations (2834) | 651178822 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1665527 | A. Stephen Moglia | 3344 N. Torrey Pines Court Suite 200 La Jolla CA 92037 | Vp, Chief Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2016-12-19 | 800 | $1.96 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Billionaire Hedge Funds
